Etoposide SPC update
The summary of product characteristics (SPC) for Vepesid (etoposide; Bristol Myers Squibb) and other etoposide SPCs has been extensively updated to reflect the core safety profile in the periodic safety update report required by medicine’s licensing agencies such as the European Medicines Agency.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200734
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com